Category: therapeutic

Novartis to Seek FDA Emergency Use Approval for New COVID-19 Therapy

Novartis said on Jan. 10 that positive data from a clinical trial of COVID-19 therapeutic drug ensovibep has prompted the firm to exercise an option to in-licence the antiviral from development partner Molecular Partners and later seek emergency use approval from U.S. regulators. In a statement, Novartis confirmed plans to pay around $163 million to…

Australia’s Medical Regulator Says No Causal Link Between Pfizer CCP Virus Vaccine and Elderly Deaths

The Therapeutic Goods Administration has cleared the Pfizer CCP virus vaccine for elderly patients, despite 30 out of 40,000 elderly people in Norway dying after receiving it. “The deaths were recorded among very frail patients, including some who were anticipated to only have weeks or months to live,” TGA said in a release on Feb. 2….